As a result, certain issues pertaining to the gut, like leaky gut syndrome and inflammatory bowel disease, may arise. The market for L-glutamine supplements is vast, with various brands and ...

Inflammatory bowel disease (IBD) is a term that encompasses two chronic diseases of the gastrointestinal tract—ulcerative colitis and Crohn's disease. Symptoms of both forms of IBD overlap and include ...

Share on Pinterest Wrist-worn devices could give advance notice of when the wearer might experience an IBD flare. Image credit: Studio Marmellata/Stocksy. For people with the unpredictable ...

Is IBD an autoimmune disease? While it has similarities with autoimmune diseases, IBD is a little different. IBD falls under the umbrella of immune-mediated inflammatory diseases (IMIDs).

It is hoping that a phase 2 trial in ulcerative colitis called IM011-127, which is using a higher dose of the drug and is due to generate results next year, will set the programme back on track.

Inflammatory bowel disease (IBD) is a group of intestinal disorders that cause prolonged inflammation of the digestive tract. It can include ulcerative colitis (UC) or Crohn’s disease.

Ulcerative colitis is a form of inflammatory bowel disease (IBD) that can cause symptoms such as bloody diarrhea, abdominal pain, and an urgent need to empty the bowels. Symptoms can alternate between ...

For people with the unpredictable conditions falling under the inflammatory bowel disease (IBD) umbrella, an early warning system for flares may one day be available in the wearable device on the ...

The results paint a stark picture of the financial challenges faced by individuals living with inflammatory bowel disease (IBD) in the United States. Our survey, which included responses from more ...

Aims: To describe the clinical features and outcomes of PSC-IBD and compare these to a group of chronic ulcerative colitis (CUC) patients. Methods: The medical records of all patients with PSC-IBD ...

AbbVie’s Skyrizi has been approved by the FDA as a treatment for ulcerative colitis, making it the first IL-23 inhibitor indicated for both major types of inflammatory bowel disease (IBD ...